• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Development and in vitro characterization of a multiparticulate delivery system for acyclovir-resinate complex

tetano

Editor, Senior Moderator
Artif Cells Nanomed Biotechnol. 2015 Mar 27:1-10. [Epub ahead of print]
[h=1]Development and in vitro characterization of a multiparticulate delivery system for acyclovir-resinate complex.[/h] Jain SK[SUP]1[/SUP], Kumar A, Kumar A, Pandey AN, Rajpoot K.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]CONTEXT:[/h] Herpes viruses cause threatening infections in humans and stand second as causative agents for most human viral diseases, after influenza and cold viruses.
[h=4]OBJECTIVE:[/h] A novel multiparticulate delivery system for acyclovir (ACV), based on ion-exchange resin, was developed to achieve a gastro-mucoadhesive effect in order to effectively combat the herpes simplex virus.
[h=4]MATERIALS AND METHODS:[/h] A combination of ACV and cholestyramine resin was optimized and further entrapped within sodium alginate and Carbopol microbeads. The developed systems were evaluated for drug entrapment efficiency (DEE), percentage of mucoadhesion, and in vitro release characteristics in simulated gastric fluid (SGF, pH 1.2).
[h=4]RESULTS:[/h] With the aid of scanning electron microscopy (SEM), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FTIR), the interaction of the resinate and polycations with alginate has been revealed, which consequently supports the formation of the membrane by the polyelectrolyte complex. The in vitro drug release studies demonstrate that formulations without the drug-resin complex (DRC) released the drug more rapidly than formulations containing DRC, which released the drug in a controlled manner, due the formation of a complex between drug and resin.
[h=4]DISCUSSION AND CONCLUSION:[/h] Preliminary results from this study suggest that these DRC-entrapped microbeads may be used to incorporate other antiviral drugs and could be effective against infections caused by herpes viruses. Such formulations developed could be subjected to in vivo studies in future, in order to prove complete clearance of herpes infections.


[h=4]KEYWORDS:[/h] acyclovir; cholestyramine; herpes viruses; microbeads; sustained release

PMID: 25813568 [PubMed - as supplied by publisher]
 
Back
Top Bottom